Nature Bioentrepreneur | Trade Secrets

Assessing VC funding in biotech

Ever since Prospect Ventures “handed back $150M “:https://www.fis.dowjones.com/WebBlogs.aspx?aid=DJFVW00020111006e7a60005l&ProductIDFromApplication=&r=wsjblog&s=djfvwof of committed money to its limited partners, there has been plenty written on the lack of venture capital funding for the life sciences. 

BACK TO ARTICLE

Tell a Friend

Please ensure that your friend is content to receive an email from us with a link to the article. Select the following link to view our Privacy Policy.

BACK TO ARTICLE